OpenBilldrug price receipt

NADAC week of 2026-10-14

BUFFERED ASPIRIN 325 MG TB

For 30 tablets

Pharmacies pay

$0.62 filed

30 × $0.02066 per EA

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-06-17 · as of 2026-10-14 · retrieved 2026-10-17

Medicare

We don’t know yet

No Medicare reference price. Part D: OpenBill did not match this NDC to a usable Medicare Part D spending row. Either Part D has none for it, or the rows that share its name could not safely be tied to it (for example, they mix units, routes or release forms, or the drug is sold over the counter, which Part D does not cover). Part B: This NDC is not in the current quarter’s Medicare Part B NDC-HCPCS crosswalk, so it has no Part B payment limit.


The spread

We don’t know yet

There is no Medicare figure to compare with, so there is no spread.

Cost-plus estimate

$5.71 estimated

$0.62 + $0.09 (15%) + $5.00 fee per fill = $5.71

This is a model, not a price any pharmacy quoted. Shipping is not included. For a pack this cheap, the $5.00 fee is most of the estimate. How it is worked out

OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-06-17 (file of 2026-10-14, retrieved 2026-10-17)

Open the interactive card Change the quantity, type what you were charged, and see every record in full.

What it is

BUFFERED ASPIRIN 325 MG TB is how the CMS NADAC file names this product. The FDA NDC Directory lists it as aspirin, under the trade name “Buffered Aspirin”.

FDA gives its dosage form as tablet, film coated and its route as oral.

The labeler, the company named on the label, is Cardinal Health 110, LLC. DBA Leader.

FDA lists it under 2 Established Pharmacologic Classes: Nonsteroidal Anti-inflammatory Drug and Platelet Aggregation Inhibitor.

The NADAC file of 2026-10-14 prices it under one NDC (National Drug Code), 70000-0147-01.

NADAC classes it as a generic drug (rate-setting class G), and marks it as sold over the counter.

What pharmacies pay

Pharmacies pay $0.62 for 30 tablets (30 × $0.02066 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-06-17. That is what pharmacies pay their suppliers, not what they charge you.

NADAC’s explanation code for it: 4, carried forward from the previous file.

This NDC’s NADAC was carried forward from an earlier file (NADAC explanation code 2 or 4), not newly surveyed: it took effect on 2026-06-17. The file is new; the price is not.

The NDC

Other strengths, forms and brands

17 other products in the NADAC file share the FDA nonproprietary name aspirin with BUFFERED ASPIRIN 325 MG TB.

ProductPharmacies pay per unitMedicare per unit
ASPIRIN 81 MG CHEWABLE TABLET
generic · tablet, chewable
$0.02571 per EA filed
eff. 2026-09-23
We don’t know yet
ASPIRIN 325 MG TABLET
generic · tablet, film coated / tablet, coated
$0.0166 per EA filed
eff. 2026-09-23
We don’t know yet
ASPIRIN EC 81 MG TABLET
generic · tablet, delayed release / tablet, coated / tablet
$0.01418 per EA filed
eff. 2026-09-23
We don’t know yet
ASPIRIN EC 325 MG TABLET
generic · tablet, delayed release / tablet, coated
$0.02216 per EA filed
eff. 2026-09-23
We don’t know yet
ASPIRIN REGIMEN 81 MG EC TAB
generic · tablet, delayed release
$0.01418 per EA filed
eff. 2026-09-23
We don’t know yet
BUFFERED ASPIRIN 325 MG TB this page
generic · tablet, film coated
$0.02066 per EA filed
eff. 2026-06-17
We don’t know yet
FT ASPIRIN 81 MG CHEWABLE TAB
generic · tablet, chewable
$0.02571 per EA filed
eff. 2026-09-23
We don’t know yet
FT ASPIRIN 325 MG TABLET
generic · tablet, film coated
$0.0166 per EA filed
eff. 2026-09-23
We don’t know yet
FT ASPIRIN EC 81 MG TABLET
generic · tablet, delayed release / tablet, coated
$0.01418 per EA filed
eff. 2026-09-23
We don’t know yet
FT ASPIRIN EC 325 MG TABLET
generic · tablet, delayed release
$0.02216 per EA filed
eff. 2026-09-23
We don’t know yet
GNP ASPIRIN 325 MG TABLET
generic · tablet, film coated
$0.0166 per EA filed
eff. 2026-09-23
We don’t know yet
GNP ASPIRIN EC 81 MG TABLET
generic · tablet, delayed release / tablet, coated
$0.01418 per EA filed
eff. 2026-09-23
We don’t know yet
GS ASPIRIN 81 MG CHEWABLE TAB
generic · tablet, chewable
$0.02571 per EA filed
eff. 2026-09-23
We don’t know yet
QC ASPIRIN 81 MG CHEWABLE TAB
generic · tablet, chewable
$0.02571 per EA filed
eff. 2026-09-23
We don’t know yet
QC ASPIRIN 325 MG TABLET
generic · tablet, film coated / tablet, coated
$0.0166 per EA filed
eff. 2026-09-23
We don’t know yet
QC ASPIRIN EC 81 MG TABLET
generic · tablet, delayed release
$0.01418 per EA filed
eff. 2026-09-23
We don’t know yet
QC ASPIRIN EC 325 MG TABLET
generic · tablet, delayed release
$0.02216 per EA filed
eff. 2026-09-23
We don’t know yet
SM ASPIRIN 81 MG CHEWABLE TAB
generic · tablet, chewable
$0.02571 per EA filed
eff. 2026-09-23
We don’t know yet

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-06-17, 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Compared with its class

Its NADAC price is $0.02066 per EA filed.

Of the 154 other products in FDA’s Nonsteroidal Anti-inflammatory Drug class priced per EA, 143 have a higher middle NADAC price and 11 a lower one. The one in the middle is ACETAMINOPHEN-IBUPROFEN 250-125 MG TABLET, at $0.10711 per EA filed (eff. 2026-10-07).

Of the 35 other products in FDA’s Platelet Aggregation Inhibitor class priced per EA, 26 have a higher middle NADAC price and 9 a lower one. The one in the middle is BACK-BODY PAIN 500-32.5 MG CPLT, at $0.04217 per EA filed (eff. 2026-09-23).

Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-06-17, 2026-09-23, 2026-10-07 · as of 2026-10-14 · retrieved 2026-10-17

What Medicare paid

We don’t know yet; the card above says why.

What to ask at the counter

None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.